CERETEC
Google image searchProduct monograph
Active ingredient
exametazime, 0.5 MG/VIAL
DIN: 02329034
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: GE HEALTHCARE CANADA INC
Date: 17-JAN-2019
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09H — INFLAMMATION AND INFECTION DETECTION (ATC, ATC/DDD)
- V09HA — Technetium (99mTc) compounds (ATC, ATC/DDD)
- V09HA02 — TECHNETIUM (99m Tc) EXAMETAZIME LABELLED CELLS (ATC/DDD)
